{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-25-008959","form_type":"8-K","ticker":"NTHI","cik":"0001979414","company_name":"NEONC TECHNOLOGIES HOLDINGS, INC.","filed_at":"2025-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.204941+00:00","generated_at":"2026-05-16T22:41:16.144962+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"NeOnc to host Nov 12 call to update on NEO100-1 trial and compassionate use data","bullets":["Investor call on Nov 12, 2025 at 9:00 a.m. ET to present data updates from Phase 1/2a NEO100-1 trial.","Discussion to include MRI radiographic response, progression-free survival (PFS), and overall survival (OS) trends.","Participants include Duke and NYU Langone neuro-oncologists; management team present.","No specific clinical results disclosed in the press release; call may provide new data."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-25-008959","json":"https://secwatch.observer/filing/0001829126-25-008959.json","markdown":"https://secwatch.observer/filing/0001829126-25-008959.md","text":"https://secwatch.observer/filing/0001829126-25-008959.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1979414/000182912625008959/0001829126-25-008959-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1979414/000182912625008959/neonctechnologies_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T22:41:16.144962+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}